Systems and methods for treating stress urinary incontinence

US12336897B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12336897-B2
Application numberUS-202318525687-A
CountryUS
Kind codeB2
Filing dateNov 30, 2023
Priority dateJun 30, 2020
Publication dateJun 24, 2025
Grant dateJun 24, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure provides improved methods and devices to create a hammock effect to stabilize the urethra without creating an incision in the abdomen or the vagina, and without using a surgical mesh. Such implementations can also leave no permanent material in the body. The simplicity afforded by such procedures and methods permits treatment of patients on an outpatient basis, and avoids risks and disadvantages associated with the installation of a permanent mesh.

First claim

Opening claim text (preview).

The invention claimed is: 1. A system for treating stress urinary incontinence (SUI), comprising: a housing; an elongate shaft extending distally from the housing; a tissue anchor removably disposed to a distal end of the elongate shaft; a tether coupled to the tissue anchor; an inflatable member surrounding and mounted to a distal region of the elongate shaft at a proximal location with respect to and near the tissue anchor, the inflatable member being configured to be selectively filled via an inflation port on the elongate shaft by an inflation medium from a source of the inflation medium through an elongate shaft inflation passageway; and an actuator disposed in the housing configured to decouple the tissue anchor from the distal end of the elongate shaft upon the actuator being actuated, wherein the elongate shaft with the inflatable member is configured to be removed as a single unit after the tissue anchor has been released to leave behind the tissue anchor and the tether. 2. The system of claim 1 , wherein the inflation port is in fluid communication with the inflation passageway and is configured to receive the inflation medium pressurized to inflate the inflatable member. 3. The system of claim 1 , wherein the elongate shaft defines a lumen along its length, and further wherein an elongate rod traverses at least part of the length of the elongate shaft from the housing to the tissue anchor. 4. The system of claim 3 , wherein the tissue anchor is configured to form a leading end of the system and the elongate rod extends distally from the tissue anchor. 5. The system of claim 1 , wherein the tether passes through an opening defined in the anchor. 6. The system of claim 1 , further comprising a vaginal anchor configured to be coupled to the tether, wherein the vaginal anchor is configured to couple to the tether after tension has been applied to the tether after the tissue anchor has been implanted. 7. The system of claim 6 , wherein the vaginal anchor includes at least one cleat configured to couple to the tether. 8. The system of claim 6 , wherein the vaginal anchor includes two housing components that couple together. 9. The system of claim 8 , wherein the two housing components clamp against the tether while the housing components are coupled together. 10. The system of claim 6 , wherein at least one of the tissue anchor, the vaginal anchor and the tether is formed from bioresorbable material. 11. The system of claim 10 , wherein the bioresorbable material includes Poly polydioxanone (PDS). 12. A system to treat stress urinary incontinence (SUI), comprising: a housing; an elongate shaft extending distally from the housing, the elongate shaft defining a first elongate passage therethrough along the length of the elongate shaft; a tissue anchor removably disposed at a distal end of the elongate shaft, the tissue anchor having a proximal end, a tapered distal tip, and defining a second elongate passage therethrough that is defined along a common longitudinal axis with the first elongate passage, and a transverse opening defined through the tissue anchor that is laterally offset from the second elongate passage; a tether traversing the transverse opening of the tissue anchor; a removable rod or wire disposed through the first elongate passage and the second elongate passage, the removable rod or wire extending through and past the tapered distal tip of the tissue anchor, the removable rod or wire terminating in a sharpened tip configured to pass through tissue; wherein, upon the removable rod or wire being withdrawn proximally out of the second elongate passage, the tissue anchor is configured to be released from the elongate shaft. 13. The system of claim 12 , wherein the tether is configured to pass over a first bearing surface defined by the tissue anchor. 14. The system of claim 12 , wherein the transverse opening is configured to not intersect the second elongate passage defined through the tissue anchor. 15. The system of claim 12 , further comprising a vaginal anchor mounted to the housing, the vaginal anchor configured to be coupled to the tether. 16. The system of claim 15 , wherein the vaginal anchor is configured to be removably disposed in the housing. 17. The system of claim 15 , wherein the vaginal anchor includes at least two housing components that are configured to couple with each other. 18. The system of claim 12 , wherein at least one of the tissue anchor, the vaginal anchor and the tether is formed from bioresorbable material.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12336897B2 cover?
The disclosure provides improved methods and devices to create a hammock effect to stabilize the urethra without creating an incision in the abdomen or the vagina, and without using a surgical mesh. Such implementations can also leave no permanent material in the body. The simplicity afforded by such procedures and methods permits treatment of patients on an outpatient basis, and avoids risks a…
Who is the assignee on this patent?
Brigham & Womens Hospital Inc, Freyja Healthcare Llc
What technology area does this patent fall under?
Primary CPC classification A61B17/0401. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).